India's Piramal Pharma gains on anti-dumping duty on Vitamin-A Palmitate imports

Piramal Pharma (Mumbai)

09/06/2025 06:52

** Shares of Piramal Pharma PIRM.NS rise as much as 3.09% to 212.70 rupees, the highest since May 15, 2025

** Stock last up 2.2%

** Uptick after Indian government imposes anti-dumping duty on Vitamin-A Palmitate imports from China, European Union and Switzerland for five years

** Says domestic industry has suffered material injury due to dumping of Vitamin-A Palmitate from China, EU and Switzerland

** Piramal Pharma is among the biggest domestic manufacturers of Vitamin-A Palmitate and stands to gain from the anti-dumping duty on Chinese, EU and Switzerland imports

** PIRM shares are down 22.5% in 2025 so far, underperforming 0.24% rise in Nifty small-cap 100 index .NIFSMCP100, exchange data shows

 (Reporting by Bharath Rajeswaran in Bengaluru)

 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))